Annexon Inc. (ANNX): Price and Financial Metrics
ANNX Price/Volume Stats
| Current price | $5.16 | 52-week high | $8.40 |
| Prev. close | $5.46 | 52-week low | $2.27 |
| Day low | $5.05 | Volume | 1,544,200 |
| Day high | $5.46 | Avg. volume | 1,815,682 |
| 50-day MA | $6.86 | Dividend yield | N/A |
| 200-day MA | $5.83 | Market Cap | 550.03M |
ANNX Stock Price Chart Interactive Chart >
Annexon Inc. (ANNX) Company Bio
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in South San Francisco, CA.
ANNX Price Returns
| 1-mo | -31.84% |
| 3-mo | -12.39% |
| 6-mo | 4.03% |
| 1-year | 105.58% |
| 3-year | -61.78% |
| 5-year | N/A |
| YTD | 13.66% |
| 2023 | -12.19% |
| 2022 | -55.00% |
| 2021 | -54.10% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...